Company intelligence

Dash Bio

BiotechFounded 2024

Is this your company? Get featured or correct your listing →

Suggest a correction

Recent changes

  1. Aug 3, 2026Raised $30M AlleyWatch
  2. Aug 3, 2026Dash Bio Raises $30M to Rebuild Drug Development Infrastructure Pulse story

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Aug 3, 2026funding round$30M—
Pulse story

Latest Pulse

  1. Dash Bio Raises $30M to Rebuild Drug Development InfrastructureDash Bio raised $30 million to build software infrastructure for drug development, part of a small but genuine wave of AI-native infrastructure plays targeting biotech's notoriously fragmented data and workflow problems.→

Coverage Timeline

newest first
  1. Aug 3, 2026FUNDINGDash Bio Raises $30M to Rebuild Drug Development Infrastructure→

All Coverage

FUNDING

Dash Bio Raises $30M to Rebuild Drug Development Infrastructure

Illustration for: Dash Bio Raises $30M to Rebuild Drug Development Infrastructure
FUNDING

Dash Bio Raises $30M to Rebuild Drug Development Infrastructure

Dash Bio raised $30 million to build software infrastructure for drug development, part of a small but genuine wave of AI-native infrastructure plays targeting biotech's notoriously fragmented data and workflow problems.

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsApnimedIambic TherapeuticsRetension PharmaceuticalsEli Lilly
Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction